Annual Working Capital
$19.34 M
-$1.04 M-5.12%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual working capital is $19.34 million, with the most recent change of -$1.04 million (-5.12%) on December 31, 2023.
- During the last 3 years, SBFM annual working capital has risen by +$19.36 million (+76234.65%).
- SBFM annual working capital is now -99.40% below its all-time high of $3.23 billion, reached on December 1, 2000.
Performance
SBFM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$21.45 M
+$1.00 M+4.91%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly working capital is $21.45 million, with the most recent change of +$1.00 million (+4.91%) on September 30, 2024.
- Over the past year, SBFM quarterly working capital has increased by +$1.11 million (+5.44%).
- SBFM quarterly working capital is now -48.78% below its all-time high of $41.88 million, reached on June 1, 2022.
Performance
SBFM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SBFM Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.1% | +5.4% |
3 y3 years | +10000.0% | +0.1% |
5 y5 years | +10000.0% | +0.1% |
SBFM Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -5.1% | +818.9% | -48.8% | +919.4% |
5 y | 5-year | -5.1% | +2618.7% | -48.8% | +2894.1% |
alltime | all time | -99.4% | +100.1% | -48.8% | +1863.7% |
Sunshine Biopharma Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $21.45 M(+4.9%) |
Jun 2024 | - | $20.45 M(-8.3%) |
Mar 2024 | - | $22.30 M(+15.3%) |
Dec 2023 | $19.34 M(-5.1%) | $19.34 M(-5.0%) |
Sep 2023 | - | $20.35 M(-5.1%) |
Jun 2023 | - | $21.44 M(+18.8%) |
Mar 2023 | - | $18.04 M(-11.5%) |
Dec 2022 | $20.38 M(+868.4%) | $20.38 M(-49.5%) |
Sep 2022 | - | $40.38 M(-3.6%) |
Jun 2022 | - | $41.88 M(+214.7%) |
Mar 2022 | - | $13.31 M(+532.4%) |
Dec 2021 | $2.10 M(-8385.8%) | - |
Dec 2021 | - | $2.10 M(+4.2%) |
Sep 2021 | - | $2.02 M(+73.0%) |
Jun 2021 | - | $1.17 M(+19.5%) |
Mar 2021 | - | $977.10 K(-3946.9%) |
Dec 2020 | -$25.40 K(-96.7%) | -$25.40 K(-88.5%) |
Sep 2020 | - | -$220.20 K(-61.6%) |
Jun 2020 | - | -$574.00 K(-22.3%) |
Mar 2020 | - | -$738.30 K(-3.8%) |
Dec 2019 | -$767.80 K(-506.2%) | -$767.80 K(-1.4%) |
Sep 2019 | - | -$778.70 K(-8.9%) |
Jun 2019 | - | -$854.80 K(-3.8%) |
Mar 2019 | - | -$888.40 K(-570.1%) |
Dec 2018 | $189.00 K(-129.8%) | $189.00 K(-131.7%) |
Sep 2018 | - | -$596.60 K(-36.5%) |
Jun 2018 | - | -$940.10 K(-3.9%) |
Mar 2018 | - | -$978.50 K(+54.4%) |
Dec 2017 | -$633.90 K(+194.0%) | -$633.90 K(+53.9%) |
Sep 2017 | - | -$412.00 K(-36.0%) |
Jun 2017 | - | -$643.30 K(+141.4%) |
Mar 2017 | - | -$266.50 K(+23.6%) |
Dec 2016 | -$215.60 K(-82.3%) | -$215.60 K(-15.1%) |
Sep 2016 | - | -$253.90 K(-77.7%) |
Jun 2016 | - | -$1.14 M(+18.8%) |
Mar 2016 | - | -$959.50 K(-21.1%) |
Dec 2015 | -$1.22 M | -$1.22 M(+265.4%) |
Sep 2015 | - | -$332.90 K(+25.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | -$265.30 K(+15.1%) |
Mar 2015 | - | -$230.50 K(-40.5%) |
Dec 2014 | -$387.60 K(+4933.8%) | -$387.60 K(+40.3%) |
Sep 2014 | - | -$276.30 K(-18.3%) |
Jun 2014 | - | -$338.20 K(+198.8%) |
Mar 2014 | - | -$113.20 K(+1370.1%) |
Dec 2013 | -$7700.00(-110.9%) | -$7700.00(-116.0%) |
Sep 2013 | - | $48.10 K(-67.1%) |
Jun 2013 | - | $146.10 K(-38.3%) |
Mar 2013 | - | $236.60 K(+236.1%) |
Dec 2012 | $70.40 K(-31.7%) | $70.40 K(-72.2%) |
Sep 2012 | - | $253.10 K(+218.0%) |
Jun 2012 | - | $79.60 K(+25.0%) |
Mar 2012 | - | $63.70 K(-38.2%) |
Dec 2011 | $103.00 K(-47.5%) | $103.00 K(-53.1%) |
Sep 2011 | - | $219.70 K(+54.2%) |
Jun 2011 | - | $142.50 K(-10.4%) |
Mar 2011 | - | $159.00 K(-19.0%) |
Dec 2010 | $196.20 K(+100.6%) | $196.20 K(+132.7%) |
Sep 2010 | - | $84.30 K(<-9900.0%) |
Jun 2010 | - | -$400.00(-103.1%) |
Mar 2010 | - | $13.10 K(-92.7%) |
Dec 2009 | $97.80 K(-328.5%) | - |
Oct 2009 | - | $179.80 K(-520.1%) |
Jul 2009 | -$42.80 K(+141.8%) | -$42.80 K(+25.9%) |
Apr 2009 | - | -$34.00 K(+21.0%) |
Jan 2009 | - | -$28.10 K(+15.6%) |
Oct 2008 | - | -$24.30 K(+37.3%) |
Jul 2008 | -$17.70 K(-232.1%) | -$17.70 K(+46.3%) |
Apr 2008 | - | -$12.10 K(-604.2%) |
Jan 2008 | - | $2400.00(-47.8%) |
Oct 2007 | - | $4600.00 |
Jul 2007 | $13.40 K(-100.0%) | - |
Dec 2003 | -$10.81 B(-20.2%) | - |
Dec 2002 | -$13.55 B(+353.2%) | - |
Dec 2001 | -$2.99 B(-192.5%) | - |
Dec 2000 | $3.23 B(-205.2%) | - |
Dec 1999 | -$3.07 B(-64.0%) | - |
Dec 1998 | -$8.54 B | - |
FAQ
- What is Sunshine Biopharma annual working capital?
- What is the all time high annual working capital for Sunshine Biopharma?
- What is Sunshine Biopharma annual working capital year-on-year change?
- What is Sunshine Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly working capital year-on-year change?
What is Sunshine Biopharma annual working capital?
The current annual working capital of SBFM is $19.34 M
What is the all time high annual working capital for Sunshine Biopharma?
Sunshine Biopharma all-time high annual working capital is $3.23 B
What is Sunshine Biopharma annual working capital year-on-year change?
Over the past year, SBFM annual working capital has changed by -$1.04 M (-5.12%)
What is Sunshine Biopharma quarterly working capital?
The current quarterly working capital of SBFM is $21.45 M
What is the all time high quarterly working capital for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly working capital is $41.88 M
What is Sunshine Biopharma quarterly working capital year-on-year change?
Over the past year, SBFM quarterly working capital has changed by +$1.11 M (+5.44%)